Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18211495rdf:typepubmed:Citationlld:pubmed
pubmed-article:18211495lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:18211495lifeskim:mentionsumls-concept:C0022548lld:lifeskim
pubmed-article:18211495lifeskim:mentionsumls-concept:C0040866lld:lifeskim
pubmed-article:18211495lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:18211495lifeskim:mentionsumls-concept:C0021490lld:lifeskim
pubmed-article:18211495pubmed:issue2lld:pubmed
pubmed-article:18211495pubmed:dateCreated2008-1-23lld:pubmed
pubmed-article:18211495pubmed:abstractTextTriamcinolone acetonide intralesional injection (TAIL) has been used for the treatment of keloids, but only with limited success. Interferon-alpha (IFN-alpha) is the most widely used IFN, and has mainly antiviral, antiproliferative, and antitumoral functions. A few studies have evaluated the efficacy of IFN-alpha2b in controlled trials for the treatment of keloids.lld:pubmed
pubmed-article:18211495pubmed:languageenglld:pubmed
pubmed-article:18211495pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18211495pubmed:citationSubsetIMlld:pubmed
pubmed-article:18211495pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18211495pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18211495pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18211495pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18211495pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18211495pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18211495pubmed:statusMEDLINElld:pubmed
pubmed-article:18211495pubmed:monthFeblld:pubmed
pubmed-article:18211495pubmed:issn1365-4632lld:pubmed
pubmed-article:18211495pubmed:authorpubmed-author:LeeAi-YoungAYlld:pubmed
pubmed-article:18211495pubmed:authorpubmed-author:KimSeong...lld:pubmed
pubmed-article:18211495pubmed:authorpubmed-author:LeeJune...lld:pubmed
pubmed-article:18211495pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18211495pubmed:volume47lld:pubmed
pubmed-article:18211495pubmed:ownerNLMlld:pubmed
pubmed-article:18211495pubmed:authorsCompleteYlld:pubmed
pubmed-article:18211495pubmed:pagination183-6lld:pubmed
pubmed-article:18211495pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:18211495pubmed:meshHeadingpubmed-meshheading:18211495...lld:pubmed
pubmed-article:18211495pubmed:meshHeadingpubmed-meshheading:18211495...lld:pubmed
pubmed-article:18211495pubmed:meshHeadingpubmed-meshheading:18211495...lld:pubmed
pubmed-article:18211495pubmed:meshHeadingpubmed-meshheading:18211495...lld:pubmed
pubmed-article:18211495pubmed:meshHeadingpubmed-meshheading:18211495...lld:pubmed
pubmed-article:18211495pubmed:meshHeadingpubmed-meshheading:18211495...lld:pubmed
pubmed-article:18211495pubmed:meshHeadingpubmed-meshheading:18211495...lld:pubmed
pubmed-article:18211495pubmed:meshHeadingpubmed-meshheading:18211495...lld:pubmed
pubmed-article:18211495pubmed:meshHeadingpubmed-meshheading:18211495...lld:pubmed
pubmed-article:18211495pubmed:meshHeadingpubmed-meshheading:18211495...lld:pubmed
pubmed-article:18211495pubmed:meshHeadingpubmed-meshheading:18211495...lld:pubmed
pubmed-article:18211495pubmed:meshHeadingpubmed-meshheading:18211495...lld:pubmed
pubmed-article:18211495pubmed:meshHeadingpubmed-meshheading:18211495...lld:pubmed
pubmed-article:18211495pubmed:meshHeadingpubmed-meshheading:18211495...lld:pubmed
pubmed-article:18211495pubmed:meshHeadingpubmed-meshheading:18211495...lld:pubmed
pubmed-article:18211495pubmed:meshHeadingpubmed-meshheading:18211495...lld:pubmed
pubmed-article:18211495pubmed:year2008lld:pubmed
pubmed-article:18211495pubmed:articleTitleEffects of interferon-alpha2b on keloid treatment with triamcinolone acetonide intralesional injection.lld:pubmed
pubmed-article:18211495pubmed:affiliationDepartment of Dermatology, Eulji Medical Center, College of Medicine, Eulji University, Seoul, and Department of Dermatology, Dongguk University School of Medicine, Kyenggi-do, South Korea.lld:pubmed
pubmed-article:18211495pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18211495pubmed:publicationTypeControlled Clinical Triallld:pubmed